Clinical Trial of Zuoqing SAN in Treating Ulcerative Colitis
Phase 1 / Phase 2 · Testing Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night and… · Sites not listed yet · The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night (a drug) and Methalazine suppository was given rectally once a day (a drug) as a possible treatment. Condition(s) listed: Ulcerative Colitis (UC).
Participants are assigned to groups by chance (randomized).
It is open-label: participants know what they are receiving.
Phase 2 studies test whether a treatment shows signs of working, and keep checking safety, in a larger group of people with the condition.
Who can join
- Ages 18 to 65
- Any sex
Some of the main requirements, copied from the record:
- See the official record.
Only the trial team can confirm whether you qualify.
What's involved
- About 60 participants are expected to take part.
- Start date: 2024-10-30 (planned).
- Main results expected around 2025-05-01 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Symptoms: frequency of stool (Follow-up for 6 months)
In the researchers’ words
The exact efficacy of Zuoqing SAN enema in the treatment of Ulcerative colitis (UC) has been clinically verified. In this study, Zuoqing SAN was used to treat UC patients with large intestine damp-heat syndrome, and the traditional chinese medicine (TCM) syndrome type was large intestine damp-heat syndrome.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Phase 1 / Phase 2 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis (UC) |
| Lead sponsor | The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine |
| Enrollment | 60 (estimated) |
| Start date | 2024-10-30 |
| Primary completion (est.) | 2025-05-01 |
| First posted | 2024-10-31 |
| Last updated | 2024-10-31 |
| Official title | Clinical Trial of Zuoqing SAN in Treating Ulcerative Colitis |
| ClinicalTrials.gov ID | NCT06667934 |
Interventions
- Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night (Drug)
Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night - Methalazine suppository was given rectally once a day (Drug)
Methalazine suppository was given rectally once a day
Full eligibility criteria (from the record)
Inclusion Criteria:① Clinically diagnosed UC; ② The severity of UC is mild to moderate. \- Exclusion Criteria:① The severity of UC is severe; ②patient with Severe liver, kidney, heart and brain diseases; ③ Patients with Chinese medicine allergy; ④ Pregnant or lactation patients. \-
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.